MedPath

Exploration of Standard Surgical Indication in Gallbladder Benign Disease

Conditions
Cholecystitis
Gallbladder Polyps
Gallbladder Stone
Registration Number
NCT02951169
Lead Sponsor
Xinhua Hospital, Shanghai Jiao Tong University School of Medicine
Brief Summary

This study evaluates life quality of patients who were diagnosed with gallbladder benign disease through Gastrointestinal Quality of Life Index (GIQLI) scale. Researchers will establish a database including 20,000 patients. Through observational followup and statistic analysis,identifing a model or scale to standardized surgical indication, help surgeons and patients determine the best treatment decision.

Detailed Description

The incidence of gallbladder benign diseases are increasing today. Most patients are accepting cholecystectomy. Is it better postoperation for this sort of patients? In other words, there is no specific indication for cholecystectomy in gallbladder benign diseases. Investigators want to explore the specific surgical indication for these patients so that surgeons could help patients make the best decision according to our evaluation model. This model may be a scale that summarizes and quantizes correlative factors of individual, which will be discussed by statisticians and experts of biliary surgery.

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
20000
Inclusion Criteria
  • Patients diagnosed with gallbladder benign disease, including gallbladder stone、cholecystitis and polypoid lesions of gallbladder from December 2016 to September 2018.
  • Have been clearly informed the purpose of this study, methods and other information, voluntarily participate in this study and sign informed consent.
Exclusion Criteria
  • Complicated with bile duct stones and other biliary tract disease or suspected with gallbladder carcinoma、biliary tract cancer.
  • Complicated with severe diseases such as organ dysfunction that cannot accept surgery
  • Abdominal operation history.
  • Pregnant or lactation.
  • Coagulopathy.

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Life Quality (Through GIQLI:Gastrointestinal Quality of Life Index)Every three months, up to 18 months

Patients with surgery must including preoperative score

Secondary Outcome Measures
NameTimeMethod
Hospital StayThrough study completion, an average of 18 months
The Rate of Accidentally Gallbladder Carcinoma During CholecystectomyThrough study completion, an average of 18 months
The Rate of Abdominal Pain After CholecystectomyThrough study completion, an average of 18 months
The Rate of Diarrhea After CholecystectomyThrough study completion, an average of 18 months
The Rate of Abdominal Distension After CholecystectomyThrough study completion, an average of 18 months
Total Expense of Patients Including Medication、Operating Costs and Check-Up ExpenseThrough study completion, an average of 18 months

Trial Locations

Locations (1)

Zhang Yong

🇨🇳

Shanghai, Shanghai, China

© Copyright 2025. All Rights Reserved by MedPath